Skip to main content
. Author manuscript; available in PMC: 2018 Jun 13.
Published in final edited form as: Mol Pharm. 2018 Feb 2;15(3):1309–1318. doi: 10.1021/acs.molpharmaceut.7b01114

Figure 3.

Figure 3

Morphology and Drug Release from Scaffolds. Scanning electron micrographs of a) Acetalated dextran blank (Ace-DEX/blank), b) 5% (wt/wt) doxorubicin (DXR) (Ace-DEX/5DXR), c) 10% (wt/wt) DXR (Ace-DEX/10DXR), d) poly lactic acid blank (PLA/blank), and e) 10% (wt/wt) DXR PLA (PLA/10DXR) scaffolds. Scale bar is the same for all images and represents 5 μm. f) Burst release of DXR from Ace-DEX/5DXR (○) and Ace-DEX/10DXR ( Inline graphic) electrospun with 60:40 ratio of HFIP to butanol. g) DXR release from Ace-DEX/10DXR ( Inline graphic) and PLA/10DXR scaffolds (◆). Table describes DXR release kinetics from Ace-DEX/10DXR and PLA/10DXR scaffolds. Burst release = DXR released over the first 24 hours. Data points for all graphs are the mean ± standard error of the mean.